This is the authors' abstract. We don't add key points for this paper.
About 1/62 patients with ATD have biopsy-verified CD. It is argued that patients with ATD should be screened for CD, given this increased prevalence.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: